tradingkey.logo

Champions Oncology Inc

CSBR

6.310USD

+0.150+2.44%
Horarios del mercado ETCotizaciones retrasadas 15 min
86.93MCap. mercado
13.53P/E TTM

Champions Oncology Inc

6.310

+0.150+2.44%
Más Datos de Champions Oncology Inc Compañía
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Información de la empresa
Símbolo de cotizaciónCSBR
Nombre de la empresaChampions Oncology Inc
Fecha de salida a bolsaNov 30, 1988
Director ejecutivoDr. Ronnie Morris, M.D.
Número de empleados213
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 30
DirecciónOne University Plaza,
CiudadHACKENSACK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal07601
Teléfono12018088400
Sitio Webhttps://championsoncology.com
Símbolo de cotizaciónCSBR
Fecha de salida a bolsaNov 30, 1988
Director ejecutivoDr. Ronnie Morris, M.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Chairman of the Board
Independent Chairman of the Board
962.13K
+12.27%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Lead Independent Director
Lead Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
30.00K
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Chairman of the Board
Independent Chairman of the Board
962.13K
+12.27%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Lead Independent Director
Lead Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
30.00K
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Desglose de ingresos
FY2025Q3
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
17.04M
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: dom., 18 de may
Actualizado: dom., 18 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Battery Management Corp
17.58%
New Enterprise Associates (NEA)
12.44%
Ackerman (Joel)
6.98%
West Elk Capital, LLC
6.41%
Morris (Ronnie)
6.23%
Other
50.36%
Accionistas
Accionistas
Proporción
Battery Management Corp
17.58%
New Enterprise Associates (NEA)
12.44%
Ackerman (Joel)
6.98%
West Elk Capital, LLC
6.41%
Morris (Ronnie)
6.23%
Other
50.36%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
25.95%
Investment Advisor
22.93%
Venture Capital
12.44%
Hedge Fund
8.24%
Investment Advisor/Hedge Fund
5.15%
Research Firm
0.71%
Pension Fund
0.08%
Other
24.51%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
69
10.40M
75.49%
-158.72K
2025Q1
71
10.39M
75.16%
-168.96K
2024Q4
61
10.19M
73.72%
-652.40K
2024Q3
60
10.19M
74.57%
-703.73K
2024Q2
64
9.36M
69.10%
-280.60K
2024Q1
64
9.22M
68.06%
-286.03K
2023Q4
62
9.19M
67.80%
-359.18K
2023Q3
68
10.27M
76.17%
-73.57K
2023Q2
73
10.30M
76.08%
-426.58K
2023Q1
98
10.36M
76.50%
-511.14K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Battery Management Corp
2.42M
17.51%
--
--
Mar 31, 2025
New Enterprise Associates (NEA)
1.71M
12.39%
--
--
Mar 31, 2025
Ackerman (Joel)
962.13K
6.96%
+105.14K
+12.27%
Oct 31, 2024
West Elk Capital, LLC
882.58K
6.38%
-210.81K
-19.28%
Sep 30, 2024
Morris (Ronnie)
858.88K
6.21%
--
--
Aug 26, 2024
Sidransky (David)
767.04K
5.55%
--
--
Aug 26, 2024
Pessin (Norman H)
742.16K
5.37%
--
--
Aug 26, 2024
Tocqueville Asset Management LP
399.88K
2.89%
-209.03K
-34.33%
Mar 31, 2025
The Vanguard Group, Inc.
307.87K
2.23%
+872.00
+0.28%
Mar 31, 2025
Mendelson (Daniel Newman)
198.63K
1.44%
+20.00
+0.01%
Aug 26, 2024
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proporción0.01%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI